Looking ahead, the immune environment of high TGF-β level associated to helminth infections suggests the promissory use of TB mucosal immunization as an alternative, or complement, to “classical” Th1 inducing vaccines in co-infection settings. This evidence concerns the gene TGFB1 and tuberculosis.